Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

A Di Giannatale; N Dias-Gastellier; Annick Devos; K Mc Hugh; A Boubaker; F Courbon; A Verschuur; S Ducassoul; K Malekzadeh; M Casanova; L Amoroso; P Chastagner; C.M. Zwaan; C Munzer; I Aerts; J Landman-Parker; R Riccardi; MC le Deley; B Geoerger; H Rubie

doi:10.1016/j.ejca.2013.08.012

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

A Di Giannatale, N Dias-Gastellier, Annick Devos, K Mc Hugh, A Boubaker, F Courbon, A Verschuur, S Ducassoul, K Malekzadeh, M Casanova, L Amoroso, P Chastagner, C.M. Zwaan, C Munzer, I Aerts, J Landman-Parker, R Riccardi, MC le Deley, B Geoerger, H Rubie

Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	170-177
Number of pages	8
Journal	European Journal of Cancer
Volume	50
Issue number	1
DOIs	https://doi.org/10.1016/j.ejca.2013.08.012
Publication status	Published - 2014

Research programs

EMC MM-02-54-03
EMC NIHES-03-30-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2013.08.012

Cite this

Di Giannatale, A., Dias-Gastellier, N., Devos, A., Mc Hugh, K., Boubaker, A., Courbon, F., Verschuur, A., Ducassoul, S., Malekzadeh, K., Casanova, M., Amoroso, L., Chastagner, P., Zwaan, C. M., Munzer, C., Aerts, I., Landman-Parker, J., Riccardi, R., le Deley, MC., Geoerger, B., & Rubie, H. (2014). Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. European Journal of Cancer, 50(1), 170-177. https://doi.org/10.1016/j.ejca.2013.08.012

@article{9b8701acfea944df9f416b077d9e2412,

title = "Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study",

author = "{Di Giannatale}, A and N Dias-Gastellier and Annick Devos and {Mc Hugh}, K and A Boubaker and F Courbon and A Verschuur and S Ducassoul and K Malekzadeh and M Casanova and L Amoroso and P Chastagner and C.M. Zwaan and C Munzer and I Aerts and J Landman-Parker and R Riccardi and {le Deley}, MC and B Geoerger and H Rubie",

year = "2014",

doi = "10.1016/j.ejca.2013.08.012",

language = "Undefined/Unknown",

volume = "50",

pages = "170--177",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "1",

}

Di Giannatale, A, Dias-Gastellier, N, Devos, A, Mc Hugh, K, Boubaker, A, Courbon, F, Verschuur, A, Ducassoul, S, Malekzadeh, K, Casanova, M, Amoroso, L, Chastagner, P, Zwaan, CM, Munzer, C, Aerts, I, Landman-Parker, J, Riccardi, R, le Deley, MC, Geoerger, B & Rubie, H 2014, 'Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study', European Journal of Cancer, vol. 50, no. 1, pp. 170-177. https://doi.org/10.1016/j.ejca.2013.08.012

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. / Di Giannatale, A; Dias-Gastellier, N; Devos, Annick et al.
In: European Journal of Cancer, Vol. 50, No. 1, 2014, p. 170-177.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

AU - Di Giannatale, A

AU - Dias-Gastellier, N

AU - Devos, Annick

AU - Mc Hugh, K

AU - Boubaker, A

AU - Courbon, F

AU - Verschuur, A

AU - Ducassoul, S

AU - Malekzadeh, K

AU - Casanova, M

AU - Amoroso, L

AU - Chastagner, P

AU - Zwaan, C.M.

AU - Munzer, C

AU - Aerts, I

AU - Landman-Parker, J

AU - Riccardi, R

AU - le Deley, MC

AU - Geoerger, B

AU - Rubie, H

PY - 2014

Y1 - 2014

U2 - 10.1016/j.ejca.2013.08.012

DO - 10.1016/j.ejca.2013.08.012

M3 - Article

C2 - 24021349

SN - 0959-8049

VL - 50

SP - 170

EP - 177

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 1

ER -